0001209191-21-002410.txt : 20210106
0001209191-21-002410.hdr.sgml : 20210106
20210106210507
ACCESSION NUMBER: 0001209191-21-002410
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210104
FILED AS OF DATE: 20210106
DATE AS OF CHANGE: 20210106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoelscher Paul W.
CENTRAL INDEX KEY: 0001611468
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 21512714
MAIL ADDRESS:
STREET 1: 520 LAKE COOK ROAD, SUITE 520
STREET 2: C/O HORIZON PHARMA, INC.
CITY: DEERFIELD
STATE: IL
ZIP: 60062
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: Horizon Pharma plc
DATE OF NAME CHANGE: 20140919
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-04
0
0001492426
Horizon Therapeutics Public Ltd Co
HZNP
0001611468
Hoelscher Paul W.
C/O HORIZON THERAPEUTICS PLC
CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD
DUBLIN
L2
4
IRELAND
0
1
0
0
EVP, CFO
Ordinary Shares
2021-01-05
4
M
0
98192
A
99241
D
Ordinary Shares
2021-01-05
4
A
0
205638
0.00
A
304879
D
Ordinary Shares
2021-01-05
4
F
0
134698
73.28
D
170181
D
Ordinary Shares
102925
I
By Trust
Restricted Stock Units (RSU)
2021-01-04
4
A
0
34928
0.00
A
Ordinary Shares
34928
34928
D
Restricted Stock Units (RSU)
2021-01-05
4
M
0
17983
0.00
D
Ordinary Shares
17983
17983
D
Restricted Stock Units (RSU)
2021-01-05
4
M
0
65696
0.00
D
Ordinary Shares
65696
0
D
Restricted Stock Units (RSU)
2021-01-05
4
M
0
14513
0.00
D
Ordinary Shares
14513
29028
D
Each RSU represents a contingent right to receive one ordinary share of the Issuer.
On January 5, 2018 and January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2020, the PSUs vested as to the number of shares reported above.
The RSU's vest 1/3rd annually on each anniversary of January 5, 2020.
The RSU's vest 1/3rd annually on each anniversary of January 5, 2019.
The RSU's vest 1/3rd annually on each anniversary of January 5, 2018.
/s/ Miles W. McHugh, Attorney-in-Fact
2021-01-06